Key facts
- This page summarizes Justin Robert Oppenheimer's Form 4 filing for Surgery Partners, Inc. (SGRY).
- 1 reported transaction and 0 derivative rows are listed below.
- Accepted by SEC: 09 Mar 2026, 19:32.
Justin Robert Oppenheimer - 05 Mar 2026 Form 4 Insider Report for Surgery Partners, Inc. (SGRY)
- Reporting relationship
- COO & National Group President
- Issuer ticker
- SGRY
- Reported as of
- 05 Mar 2026
- Net transaction value
- $0
- SEC form
- 4
- Accepted by SEC
- 09 Mar 2026, 19:32:43 UTC
- Prior SEC filing
- 15 Jan 2026
- Source filing
- View source filing
- Reporting owner signature
- /s/ Jennifer Baldock, Attorney-in-Fact
Source evidence
Original filing metadata and source links for verification.
4 source fields
Reporting owner
1 detail
Key filing fact
Justin Robert Oppenheimer filed Form 4 for Surgery Partners, Inc. (SGRY) on 09 Mar 2026.
Change
- Previous filing in this sequence was filed on 15 Jan 2026.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reporting Owners (1)
CIK 0002100574
Primary reporting owner
Oppenheimer Justin Robert
- Relationship
- COO & National Group President
- Address
- 340 SEVEN SPRINGS WAY, SUITE 600, BRENTWOOD
- Signature
- /s/ Jennifer Baldock, Attorney-in-Fact
- Signature date
- 09 Mar 2026
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
SGRY
transaction
Common Stock
Award
- Transaction value
- Shares
- +42,523
- Change %
- +55%
- Price
- $14.11*
- Shares after
- 120,259
- Date
- 05 Mar 2026
- Ownership
- Direct
- Footnotes
- F1
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 1 footnote
Footnote F1
Represents restricted stock awards ("RSAs") granted to the reporting person on March 5, 2026 (the "Grant Date"). The RSAs vest in three equal annual installments beginning on the first anniversary of the Grant Date.